Teva Pharmaceutical Industries to seek EC approval for USD6.8 bln Cephalon purchase
Global pharmaceutical company Teva will seek European Commission approval for its planned acquisition of biopharmaceutical company Cephalon. The tie-up announcement comes just days after the commission opened a formal antitrust investigation...To view the full article, register now.
Already a subscriber? Click here to view full article